Maraviroc decreases CCL8-mediated migration of CCR5+ regulatory T cells and reduces metastatic tumor growth in the lungs EC Halvorsen, MJ Hamilton, A Young, BJ Wadsworth, NE LePard, ... Oncoimmunology 5 (6), e1150398, 2016 | 103 | 2016 |
Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype VA Fajardo, E Bombardier, E McMillan, K Tran, BJ Wadsworth, D Gamu, ... Disease models & mechanisms 8 (8), 999-1009, 2015 | 45 | 2015 |
ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP … EB Button, GK Boyce, A Wilkinson, S Stukas, A Hayat, J Fan, ... Alzheimer's research & therapy 11, 1-18, 2019 | 43 | 2019 |
IL-33 increases ST2+ Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner EC Halvorsen, SE Franks, BJ Wadsworth, BT Harbourne, RA Cederberg, ... Oncoimmunology 8 (2), e1527497, 2019 | 34 | 2019 |
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development ES Melese, E Franks, RA Cederberg, BT Harbourne, R Shi, ... Oncoimmunology 11 (1), 2010905, 2022 | 21 | 2022 |
Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation BJ Wadsworth, RA Cederberg, CM Lee, NS Firmino, SE Franks, J Pan, ... Cancer Letters 493, 31-40, 2020 | 12 | 2020 |
Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours VD Martinez, NS Firmino, EA Marshall, KW Ng, BJ Wadsworth, ... Scientific Reports 8 (1), 152, 2018 | 11 | 2018 |
Eosinophils decrease pulmonary metastatic mammary tumor growth RA Cederberg, SE Franks, BJ Wadsworth, A So, LR Decotret, MG Hall, ... Frontiers in Oncology 12, 841921, 2022 | 7 | 2022 |
Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts BJ Wadsworth, CM Lee, KL Bennewith British Journal of Cancer 126 (11), 1616-1626, 2022 | 7 | 2022 |
Receptor-type protein tyrosine phosphatase alpha (PTPα) mediates MMP14 localization and facilitates triple-negative breast cancer cell invasion LR Decotret, BJ Wadsworth, LV Li, CJ Lim, KL Bennewith, CJ Pallen Molecular Biology of the Cell 32 (7), 567-578, 2021 | 6 | 2021 |
Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy PP Cunha, E Minogue, LCM Krause, RM Hess, D Bargiela, BJ Wadsworth, ... Elife 12, e84280, 2023 | 5 | 2023 |
Glutarate regulates T cell metabolism and anti-tumour immunity E Minogue, PP Cunha, BJ Wadsworth, GL Grice, SK Sah-Teli, R Hughes, ... Nature Metabolism 5 (10), 1747-1764, 2023 | 4 | 2023 |
Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer NS Firmino, RA Cederberg, CM Lee, R Shi, BJ Wadsworth, SE Franks, ... Oncoimmunology 10 (1), 1959978, 2021 | 4 | 2021 |
2-18F-Fluoroethanol Is a PET Reporter of Solid Tumor Perfusion BJ Wadsworth, J Pan, I Dude, N Colpo, M Bosiljcic, KS Lin, F Benard, ... Journal of Nuclear Medicine 58 (5), 815-820, 2017 | 4 | 2017 |
Glutarate regulates T cell function and metabolism E Minogue, PP Cunha, A Quaranta, J Zurita, SS Teli, BJ Wadsworth, ... bioRxiv, 2022.10. 20.513065, 2022 | 3 | 2022 |
Evaluation of 18F-EF5 for detection of hypoxia in localized adenocarcinoma of the prostate BJ Wadsworth, LR Decotret, C Villamil, D Yapp, D Wilson, F Benard, ... Acta Oncologica 60 (11), 1489-1498, 2021 | 3 | 2021 |
Abstract PR-001: Angiotensin II receptor blockers modify the solid tumor microenvironment and improve radiation therapy response BJ Wadsworth, CM Lee, R Urban, SN Hamilton, KL Bennewith Clinical Cancer Research 27 (8_Supplement), PR-001-PR-001, 2021 | 1 | 2021 |
A 2-Hydroxybutyrate-mediated feedback loop regulates muscular fatigue BJ Wadsworth, M Leiwe, E Minogue, PP Cunha, V Engman, C Brombach, ... bioRxiv, 2023.10. 16.562554, 2023 | | 2023 |
Abstract PO-034: Changes in cancer associated fibroblast subsets following angiotensin II type I receptor blocker (ARB) treatment reduces transient hypoxia and radiation resistance CM Lee, BJ Wadsworth, KL Bennewith Clinical Cancer Research 27 (8_Supplement), PO-034-PO-034, 2021 | | 2021 |
Changes in cancer associated fibroblast subsets following angiotensin II type I receptor blocker (ARB) treatment reduces transient hypoxia and radiation resistance. CM Lee, BJ Wadsworth, KL Bennewith CLINICAL CANCER RESEARCH 27 (8), 2021 | | 2021 |